STOCK TITAN

Amundi discloses 61.5M-share stake in Sanofi (NYSE: SNY)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

SANOFI reported a Schedule 13G/A showing Amundi and Amundi Asset Management beneficially own 61,506,935 shares, representing 5.04% of the class.

The filing states Amundi holds shared voting power for 30,913,607 shares and shared dispositive power for 61,506,935. It notes 27,407,379 shares are held in an employee FCPE whose voting rights are exercised by the FCPE supervisory board.

Positive

  • None.

Negative

  • None.
Beneficial ownership 61,506,935 shares Item 4 beneficially owned
Percent of class 5.04% Item 4 percent of class
Shared voting power 30,913,607 shares Item 4 shared power to vote
FCPE-held shares (no Amundi voting) 27,407,379 shares Comment: held through employee FCPE
Schedule 13G/A regulatory
"Amendment No. 11 ) SANOFI Common Stock and American Depositary Receipts"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
FCPE (Fonds Commun de Placement d'Entreprise) financial
"held through a FCPE (Fonds Commun de Placement d'Enterprise, an investment vehicle"
Shared dispositive power regulatory
"Shared power to dispose or to direct the disposition of: 61,506,935"





80105N105

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Amundi does not have voting rights on 27,407,379 shares which are held through a FCPE (Fonds Commun de Placement d'Enterprise, an investment vehicle established under French law), solely dedicated to Sanofi group's employees shareholding. Employees of Sanofi are granted the right to participate in stock purchase plans in which the shares acquired are exclusively held in this FCPE, created at the request of Sanofi. The voting rights associated to these shares are exercised by the supervisory Board of the FCPE, where representatives of the employees have the majority (if any remaining seats of the supervisory board are designated by Sanofi), and not by Amundi.


SCHEDULE 13G




Comment for Type of Reporting Person: Amundi does not have voting rights on 27,407,379 shares which are held through a FCPE (Fonds Commun de Placement d'Enterprise, an investment vehicle established under French law), solely dedicated to Sanofi group's employees shareholding. Employees of Sanofi are granted the right to participate in stock purchase plans in which the shares acquired are exclusively held in this FCPE, created at the request of Sanofi. The voting rights associated to these shares are exercised by the supervisory Board of the FCPE, where representatives of the employees have the majority (if any remaining seats of the supervisory board are designated by Sanofi), and not by Amundi.


SCHEDULE 13G



AMUNDI
Signature:John M. Malone
Name/Title:John M. Malone | Chief Compliance Officer | Power of Attorney
Date:04/10/2026
AMUNDI ASSET MANAGEMENT
Signature:John M. Malone
Name/Title:John M. Malone | Chief Compliance Officer | Power of Attorney
Date:04/10/2026